- Home
- CGEN vs MHF Comparison
CGEN vs MHF Comparison
Compare CGEN & MHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGEN
- MHF
- Stock Information
- Founded
- CGEN 1993
- MHF 1988
- Country
- CGEN Israel
- MHF United States
- Employees
- CGEN 74
- MHF N/A
- Industry
- CGEN Biotechnology: Biological Products (No Diagnostic Substances)
- MHF Finance/Investors Services
- Sector
- CGEN Health Care
- MHF Finance
- Exchange
- CGEN Nasdaq
- MHF Nasdaq
- Market Cap
- CGEN 125.3M
- MHF 148.8M
- IPO Year
- CGEN 2000
- MHF N/A
- Fundamental
- Price
- CGEN $1.38
- MHF $7.39
- Analyst Decision
- CGEN
- MHF
- Analyst Count
- CGEN 0
- MHF 0
- Target Price
- CGEN N/A
- MHF N/A
- AVG Volume (30 Days)
- CGEN 238.3K
- MHF 57.2K
- Earning Date
- CGEN 11-11-2025
- MHF 01-01-0001
- Dividend Yield
- CGEN N/A
- MHF 4.29%
- EPS Growth
- CGEN N/A
- MHF N/A
- EPS
- CGEN N/A
- MHF N/A
- Revenue
- CGEN $22,144,000.00
- MHF N/A
- Revenue This Year
- CGEN N/A
- MHF N/A
- Revenue Next Year
- CGEN $159.40
- MHF N/A
- P/E Ratio
- CGEN N/A
- MHF N/A
- Revenue Growth
- CGEN N/A
- MHF N/A
- 52 Week Low
- CGEN $1.13
- MHF $5.92
- 52 Week High
- CGEN $2.66
- MHF $6.79
- Technical
- Relative Strength Index (RSI)
- CGEN 41.92
- MHF 70.92
- Support Level
- CGEN $1.39
- MHF $7.11
- Resistance Level
- CGEN $1.47
- MHF $7.50
- Average True Range (ATR)
- CGEN 0.06
- MHF 0.14
- MACD
- CGEN -0.00
- MHF 0.05
- Stochastic Oscillator
- CGEN 33.33
- MHF 84.72
About CGEN Compugen Ltd.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
About MHF Western Asset Municipal High Income Fund Inc.
Western Asset Municipal High Income Fund Inc is a diversified closed-end management investment company. The company's objective is to seek high current income exempt from federal income taxes. It invests predominantly in intermediate and long-term municipal debt securities issued by state and local governments.